Low dose synthetic human atrial natriuretic peptide infusion in a patient with mitral stenosis and severe pulmonary hypertension

Japanese Circulation Journal

Volumn 63, Issue 10, 1999, Pages 816-818

  Maeda, Keiko ^a   Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Hisanaga, Tomoko ^a   Nishimura, Tamaki ^a   Yamada, Hisao ^a   Sasaki, Yasushi ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Atrial natriuretic peptide; Fibrosis; Heart failure; Mitral stenosis

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG SCREENING; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; MALE; MITRAL VALVE STENOSIS; PULMONARY HYPERTENSION;

ATRIAL NATRIURETIC FACTOR; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PULMONARY WEDGE PRESSURE; TIME FACTORS;

EID: 0032853973     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.816     Document Type: Article

References (13)

1. de Bold AJ, Borenstein HB, Veress AT Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94
2. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, et al: Atrial natriuretic factor in normal subjects and heart failure patients: Plasma levels and renal, hemodynamic responses to peptide infusion. J Clin Invest 1986; 78: 1362-1374
3. Saito Y, Nakao K, Nishimura K, Sugawara A, Okamura K, Obata K, et al: Clinical application of atrial natriuretic peptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987; 6: 115-124
4. Yoshimura M, Yasue H, Okamura K, Ogawa H, Jougasaki M, Mukoyama M, et al: Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-469
5. Macus LS, Hart D, Packer M, Yushak M, Medina N, Danziger RS, et al: Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a double-blind, placebo-controlled, randomized crossover trial. Circulation 1996; 94: 3184-3189
6. Tsutamoto T, Kanamori T, Wada A, Kinoshita M: Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol 1992; 20: 541-546
7. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka Y, Kinoshita M: Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic heart failure. Circulation 1993; 87: 70-75
8. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832
9. Feigenbaum H: Echocardiography. Pennsylvania: Lea and Febiger, 1993: 195-198
10. Nishimura T, Mizukawa K, Nakao K, Yamada H, Kinoshita M, Ochi J: Atrial natriuretic peptide-immunoreactivity and specific atrial granules in cardiac myocytes of the stroke-prone spontaneously hypertensive rat. Arch Histol Cytol 1994; 57: 1-7
11. Yasue H, Obata K, Okumura H, Kurose M, Ogawa H, Matsuyama K, et al: Increased secretion of atrial natriuretic peptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46-51
12. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, et al: Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208
13. Nishimura K, Matsuda K, Konno S, Sugimoto A, Koshiji T, Ikeda T, et al: Beneficial effect of synthetic human atrial natriuretic polypeptide on renal function in a patient with giant atria. J Thorac Cardiovasc Surg 1997; 113: 793-795